Partnerships

Zero-emission waterborne transport

Zero-emission waterborne transport

Partnership website: https://www.waterborne.eu/

The partnership will provide and demonstrate zero-emission solutions for all main ship types and services before 2030, which will enable zero-emission waterborne transport before 2050. 

In addition, the partnership will

  • develop and demonstrate deployable technological solutions which will be applicable for the decarbonisation and elimination of other harmful emissions of main ship types and services
  • facilitate the implementation of economically viable European new technologies and concepts regarding zero-emission waterborne transport, to strengthen the competitiveness of European industries in growing green ship technology markets and provide the capability to re-enter markets presently dominated by Europe’s competitors
  • facilitate the development and implementation of regulations and policies at national and international level, including the development of standards to enable the implementation of technological solutions for zero-emission waterborne transport by 2030 at the latest
  • facilitate the uptake of innovative zero-emission waterborne transport technologies and solutions within the European waterborne sector, supporting economic growth and European employment 

Contact

Commission services:RTD-CLEAN-WATERBORNE@ec.europa.eu

Partners: Waterborne Technology Platform - Jaap Gebraad, Partnership website

What are partnerships?

Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.

More detailed info Overview of partnerships

How to use partnerships?

  • orientation
    Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.
  • networking
    Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.
  • ecosystem analysis
    Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.
  • steering the agenda
    Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article Check out the other testimonials 
Logo of FWO
Logo of VLAIO

NCP Flanders

Updates

Our Services

Legal mentions

Privacy Policy
Cookies

LinkedIn